Free Trial

CLS (LON:CLI) Insider Acquires £149.42 in Stock

CLS logo with Real Estate background

Key Points

  • Insider Andrew Kirkman acquired 241 shares of CLS Holdings plc stock at an average price of GBX 62, totaling £149.42, on October 8th.
  • The company reported a negative earnings per share (EPS) of GBX (6.10) for the last quarter, with analysts forecasting EPS of 10.01 for the current year.
  • Analyst ratings for CLS stock include a drop in price target from GBX 100 to GBX 85, with an average consensus rating of "Buy."
  • Five stocks to consider instead of CLS.

CLS Holdings plc (LON:CLI - Get Free Report) insider Andrew Kirkman acquired 241 shares of CLS stock in a transaction on Wednesday, October 8th. The stock was acquired at an average price of GBX 62 per share, with a total value of £149.42.

Andrew Kirkman also recently made the following trade(s):

  • On Monday, September 8th, Andrew Kirkman acquired 264 shares of CLS stock. The stock was acquired at an average price of GBX 57 per share, with a total value of £150.48.
  • On Friday, August 8th, Andrew Kirkman acquired 227 shares of CLS stock. The stock was acquired at an average price of GBX 66 per share, with a total value of £149.82.

CLS Stock Up 0.8%

Shares of LON:CLI opened at GBX 60.55 on Friday. The company has a market capitalization of £241.06 million, a PE ratio of -423.44 and a beta of 1.01. The company has a debt-to-equity ratio of 123.30, a current ratio of 0.73 and a quick ratio of 0.59. The business has a fifty day moving average price of GBX 60.07 and a two-hundred day moving average price of GBX 63.02. CLS Holdings plc has a 1 year low of GBX 53 and a 1 year high of GBX 101.40.

CLS (LON:CLI - Get Free Report) last announced its quarterly earnings data on Wednesday, August 13th. The company reported GBX (6.10) earnings per share (EPS) for the quarter. CLS had a negative net margin of 134.11% and a negative return on equity of 23.42%. Analysts forecast that CLS Holdings plc will post 10.0104167 earnings per share for the current year.

Analyst Ratings Changes

Separately, Berenberg Bank dropped their price target on CLS from GBX 100 to GBX 85 and set a "buy" rating on the stock in a research report on Thursday, September 4th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, CLS presently has an average rating of "Buy" and a consensus target price of GBX 85.

Check Out Our Latest Analysis on CLI

CLS Company Profile

(Get Free Report)

We are a commercial property investment company with a £2.1bn portfolio listed on the Premium Main Market on the London Stock Exchange, specialising in future-focused office space in the UK, Germany and France. Through geographical diversification, local expertise and an active management approach, we transform office properties into sustainable, modern spaces that help our tenants' businesses to grow.

Further Reading

Insider Buying and Selling by Quarter for CLS (LON:CLI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CLS Right Now?

Before you consider CLS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CLS wasn't on the list.

While CLS currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.